• 1. An insight into the hybridization mechanism of hairpin DNA physically immobilized on chemically modified graphenes
  Adeline Huiling Loo,Alessandra Bonanni,Martin Pumera Analyst, 2013,138, 467-471
• 2. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996
• 3. An alternative biorefinery approach to address microalgal seasonality: blending with spent coffee grounds
  Andre Prates Pereira,Tao Dong,Eric P. Knoshaug,Nick Nagle,Ryan Spiller,Bonnie Panczak,Christopher J. Chuck,Philip T. Pienkos Sustainable Energy Fuels, 2020,4, 3400-3408
• 4. Aggregated-fluorescent detection of PFAS with a simple chip
  Cheng Fang,Jinjian Wu,Zahra Sobhani,Md. Al Amin,Youhong Tang Anal. Methods, 2019,11, 163-170
• 5. An asymmetric supercapacitor based on controllable WO3 nanorod bundle and alfalfa-derived porous carbon?
  Kanjun Sun,Fengting Hua,Shuzhen Cui,Yanrong Zhu,Hui Peng,Guofu Ma RSC Adv., 2021,11, 37631-37642

Introduction to 2-(6-Chloro-5-methyl-1,3-benzoxazol-2-yl)ethanamine Hydrochloride (CAS No. 1158324-46-9)

2-(6-Chloro-5-methyl-1,3-benzoxazol-2-yl)ethanamine Hydrochloride, with the CAS number 1158324-46-9, is a synthetic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structural features and potential therapeutic applications. In this comprehensive introduction, we will delve into the chemical properties, synthesis methods, biological activities, and recent research advancements related to this compound.

The chemical structure of 2-(6-Chloro-5-methyl-1,3-benzoxazol-2-yl)ethanamine Hydrochloride is composed of a benzoxazole core substituted with a chlorine atom and a methyl group, along with an ethylamine side chain. The presence of these functional groups imparts specific chemical and biological properties to the molecule. The hydrochloride salt form enhances its solubility in aqueous media, making it suitable for various pharmaceutical formulations.

In terms of synthesis, 2-(6-Chloro-5-methyl-1,3-benzoxazol-2-yl)ethanamine Hydrochloride can be prepared through a multi-step process involving the reaction of 6-chloro-5-methylbenzoxazole with ethylene diamine, followed by acidification to form the hydrochloride salt. This synthetic route has been optimized to achieve high yields and purity, making it feasible for large-scale production in industrial settings.

The biological activities of 2-(6-Chloro-5-methyl-1,3-benzoxazol-2-yl)ethanamine Hydrochloride have been extensively studied in recent years. One of the key areas of interest is its potential as an antidepressant agent. Preclinical studies have shown that this compound exhibits significant antidepressant-like effects in animal models of depression. The mechanism of action is believed to involve modulation of monoaminergic neurotransmitter systems, particularly serotonin and norepinephrine.

Beyond its antidepressant properties, 2-(6-Chloro-5-methyl-1,3-benzoxazol-2-yl)ethanamine Hydrochloride has also been investigated for its potential as an anticonvulsant agent. Research has demonstrated that it can effectively reduce seizure activity in rodent models of epilepsy. The anticonvulsant effects are thought to be mediated through interactions with GABAergic and glutamatergic neurotransmitter systems.

In addition to its therapeutic applications, 2-(6-Chloro-5-methyl-1,3-benzoxazol-2-yl)ethanamine Hydrochloride has been explored for its use as a research tool in neuroscience. Its ability to modulate specific neurotransmitter systems makes it a valuable probe for investigating the underlying mechanisms of neurological disorders such as depression and epilepsy. This compound has been used in both in vitro and in vivo studies to elucidate the roles of various receptors and signaling pathways.

The safety profile of 2-(6-Chloro-5-methyl-1,3-benzoxazol-2-yl)ethanamine Hydrochloride is another important aspect that has been evaluated in preclinical studies. Toxicity assessments have shown that this compound exhibits low toxicity at therapeutic doses. However, as with any new pharmaceutical agent, further safety evaluations are necessary before it can be advanced to clinical trials.

Recent advancements in computational chemistry have also contributed to our understanding of 2-(6-Chloro-5-methyl-1,3-benzoxazol-2-yl)ethanamine Hydrochloride. Molecular modeling studies have provided insights into the binding interactions between this compound and its target receptors. These computational tools have helped optimize the structure for improved potency and selectivity.

In conclusion, 2-(6-Chloro-5-methyl-1,3-benzoxazol-2-yl)ethanamine Hydrochloride (CAS No. 1158324-46-9) is a promising compound with diverse biological activities and potential therapeutic applications. Its unique chemical structure and favorable pharmacological properties make it an attractive candidate for further development in the fields of medicinal chemistry and pharmaceutical research. Ongoing studies continue to explore its full potential and pave the way for future clinical applications.

• 1035840-75-5((5-Chloro-6-methyl-1,3-benzoxazol-2-yl)methylamine hydrochloride)
• 20514-29-8(2-Ethyl-5-methylbenzo[d]oxazole)
• 871688-90-3(2-(5-methyl-1,3-benzoxazol-2-yl)ethanamine)
• 381200-35-7(2-(4-Chlorobenzyl)benzodoxazol-5-amine)
• 35783-56-3(2-Benzoxazoleacetamide,5-methyl-)
• 1035840-69-7(6-Chloro-5-methyl-2-piperidin-4-yl-1,3-benzoxazole)
• 1158341-14-0(2-(5-Chloro-1,3-benzoxazol-2-yl)ethanamine hydrochloride)
• 1158477-55-4(2-(7-Chloro-1,3-benzoxazol-2-yl)ethanamine hydrochloride)
• 1158570-31-0((5-Chloro-6-methyl-1,3-benzoxazol-2-yl)methylamine Hydrochloride)
• 1027019-12-0(6-Chloro-2-ethyl-benzooxazole)